Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, S-413 45 Gothenburg, Sweden.
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):912-919. doi: 10.1016/j.bbadis.2018.07.004. Epub 2018 Jul 6.
The gut microbiota affects host physiology and has evolved as an important contributor to health and disease. Gut and liver are closely connected and communicate via the portal vein and the biliary system so the liver is constantly exposed to gut-derived bacterial products and metabolites. The intestinal barrier is important for maintaining physical and functional separation between microbes in the gut and the interior of the host and disruption of the barrier function can lead to bacterial translocation and increased leakage of bacterial metabolites. Liver diseases have been associated with dysbiotic changes in the gut microbiota and impaired gut barrier integrity, thus a future strategy to treat liver disease may be to target the gut microbiota and thereby restore the gut barrier function. This review will summarize and discuss studies that have shown a link between the gut microbiota and liver disease with the main focus on non-alcoholic fatty liver disease and alcoholic liver disease.
肠道微生物群影响宿主的生理机能,并且已经进化成为健康和疾病的重要贡献者。肠道和肝脏紧密相连,并通过门静脉和胆道系统进行交流,因此肝脏不断暴露于肠道来源的细菌产物和代谢物中。肠道屏障对于维持肠道内微生物和宿主内部之间的物理和功能分隔非常重要,屏障功能的破坏可导致细菌易位和细菌代谢物的泄漏增加。肝脏疾病与肠道微生物群的失调和肠道屏障完整性受损有关,因此治疗肝脏疾病的未来策略可能是针对肠道微生物群,从而恢复肠道屏障功能。这篇综述将总结和讨论表明肠道微生物群与肝脏疾病之间存在关联的研究,主要关注非酒精性脂肪性肝病和酒精性肝病。